These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 17709295)

  • 1. Effects of levetiracetam vs topiramate and placebo on visually evoked phase synchronization changes of alpha rhythm in migraine.
    de Tommaso M; Marinazzo D; Nitti L; Pellicoro M; Guido M; Serpino C; Stramaglia S
    Clin Neurophysiol; 2007 Oct; 118(10):2297-304. PubMed ID: 17709295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visually evoked phase synchronization changes of alpha rhythm in migraine: correlations with clinical features.
    de Tommaso M; Marinazzo D; Guido M; Libro G; Stramaglia S; Nitti L; Lattanzi G; Angelini L; Pellicoro M
    Int J Psychophysiol; 2005 Sep; 57(3):203-10. PubMed ID: 16109290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients.
    de Tommaso M; Guido M; Sardaro M; Serpino C; Vecchio E; De Stefano G; Di Claudio T; Specchio LM; Livrea P
    Neurosci Lett; 2008 Sep; 442(2):81-5. PubMed ID: 18620023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effects of low frequency repetitive transcranial magnetic stimulation on alpha rhythm phase synchronization in migraine patients.
    de Tommaso M; Stramaglia S; Brighina F; Fierro B; Francesco VD; Todarello O; Serpino C; Pellicoro M
    Neurosci Lett; 2011 Jan; 488(2):143-7. PubMed ID: 21075171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and effective connectivity in EEG alpha and beta bands during intermittent flash stimulation in migraine with and without aura.
    de Tommaso M; Stramaglia S; Marinazzo D; Trotta G; Pellicoro M
    Cephalalgia; 2013 Aug; 33(11):938-47. PubMed ID: 23439574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visually evoked phase synchronisation changes of alpha rhythm in migraine. Correlations with clinical features.
    de Tommaso M; Stramaglia S; Marinazzo D; Guido M; Lamberti P; Livrea P
    Neurol Sci; 2004 Oct; 25 Suppl 3():S283-4. PubMed ID: 15549562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial.
    Diener HC; Agosti R; Allais G; Bergmans P; Bussone G; Davies B; Ertas M; Lanteri-Minet M; Reuter U; Sánchez Del Río M; Schoenen J; Schwalen S; van Oene J;
    Lancet Neurol; 2007 Dec; 6(12):1054-62. PubMed ID: 17988947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of migraine on daily activities: effect of topiramate compared with placebo.
    Silberstein SD; Loder E; Forde G; Papadopoulos G; Fairclough D; Greenberg S
    Curr Med Res Opin; 2006 Jun; 22(6):1021-9. PubMed ID: 16846536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
    Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
    Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G; Diener HC; Pfeil J; Schwalen S
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study.
    Mei D; Capuano A; Vollono C; Evangelista M; Ferraro D; Tonali P; Di Trapani G
    Neurol Sci; 2004 Dec; 25(5):245-50. PubMed ID: 15624081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.